Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
199.90    -9.30 (-4.45%)
Bid:
202.20
Ask:
202.40
Spread: 0.20 (0.099%)
Market Cap: £1.66b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Ocado and AutoStore settle all Litigation

24 Jul 2023 07:00

RNS Number : 8733G
Ocado Group PLC
22 July 2023
 

This Announcement contains Inside Information

 

OCADO GROUP PLC22 July 2023

 

Ocado Group plc

Ocado and AutoStore settle all Litigation

 

Ocado Group plc ("Ocado" or the "Company") today announces that the litigation between Ocado and AutoStore has been settled and each party is taking steps to withdraw their actions against the other party. The terms of the settlement are confidential, however we can disclose that:

1. There is a cross-licence of certain patents between the parties whereby:

● Ocado and AutoStore have complete freedom to access and use technology covered by each other's pre-2020 patents

● Ocado and AutoStore are allowed to continue to use and market their own existing products without challenge of infringement of the other's post-2020 patents

AutoStore is not permitted to make or use a single-space cavity robot in any jurisdiction where Ocado has patent protection.

2. AutoStore will pay £200m to Ocado. This will be paid in 24 monthly instalments, starting in July 2023. 

3. The agreement gives access to part of each party's patent portfolio for them to use or develop their own products. It does not provide for collaboration, technology assistance or access to actual products.

Tim Steiner, Chief Executive Officer of Ocado Group plc, said: 

"I am pleased that we have worked together to resolve our differences and can now continue to focus on what we do best - innovating, developing and enabling partners to access world beating technology"

Neill Abrams, Group General Counsel and Company Secretary, said:

"I'm delighted that this litigation has now ended on satisfactory terms. I'd like to thank the internal Ocado IP team and our external counsel for their immense efforts in getting to this result."

 Contacts:

● Tim Steiner, Chief Executive Officer, on +44 1707 228 000

● Neill Abrams, Group General Counsel, on +44 1707 228 000

● David Shriver, Chief Reputation Officer, on +44 1707 228 000

Louise Male at Teneo, on +44 20 7353 4200

 

Person responsible for arranging the release of this announcement:

Neill AbramsGroup General Counsel & Company SecretaryOcado Group plcBuildings One & Two Trident Place Mosquito WayHatfield, HertfordshireAL10 9ULFax: +44 (0)1707 228 000email: company.secretary@ocado.comOcado Group plc LEI: 213800LO8F61YB8MBC74

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBDGDRUSDDGXD
Date   Source Headline
2nd Jun 20261:43 pmRNSDirector/PDMR Shareholding
1st Jun 20263:09 pmRNSTotal Voting Rights
29th May 20267:00 amRNSOcado Group & Asda to enter ecommerce partnership
28th May 20268:11 amRNSDirector Declaration
19th May 20269:26 amRNSDirector/PDMR Shareholding
19th May 20268:33 amRNSAdmission to Trading
1st May 202611:31 amRNSTotal Voting Rights
28th Apr 20263:53 pmRNSResult of AGM
20th Apr 202611:07 amRNSHolding(s) in Company
16th Apr 20264:05 pmRNSDirector/PDMR Shareholding
14th Apr 202611:25 amRNSAdmission to Trading
7th Apr 202612:54 pmRNSDirector/PDMR Shareholding
7th Apr 202610:51 amRNSHolding(s) in Company
1st Apr 202611:24 amRNSTotal Voting Rights
30th Mar 20263:54 pmRNSDirector/PDMR Shareholding
18th Mar 202610:22 amRNSHolding(s) in Company
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
5th Mar 202611:00 amRNSAnnual Financial Report and Notice of Meeting
3rd Mar 20262:59 pmRNSDirector/PDMR Shareholding
3rd Mar 20262:56 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:57 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSPreliminary Results
17th Feb 20263:19 pmRNSDirector/PDMR Shareholding
5th Feb 20263:50 pmRNSHolding(s) in Company
5th Feb 20263:23 pmRNSHolding(s) in Company
5th Feb 20268:29 amRNSHolding(s) in Company
3rd Feb 20266:09 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSDirector Declaration
2nd Feb 20264:40 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSUpdate on Sobeys Partnership
28th Jan 20264:26 pmRNSHolding(s) in Company
27th Jan 20264:57 pmRNSBlock Listing Interim Review
22nd Jan 20263:07 pmRNSHolding(s) in Company
20th Jan 20263:25 pmRNSHolding(s) in Company
16th Jan 20262:06 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSHolding(s) in Company
9th Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 202610:46 amRNSTotal Voting Rights
30th Dec 20257:00 amRNSExclusivity with International Partners
30th Dec 20257:00 amRNSExclusivity with International Partners
23rd Dec 20254:03 pmRNSHolding(s) in Company
23rd Dec 20254:03 pmRNSHolding(s) in Company
16th Dec 202511:45 amRNSDirector/PDMR Shareholding
9th Dec 202510:23 amRNSRedemption of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.